(Reuters) - BioCryst Pharmaceuticals Inc said its experimental hepatitis C drug showed promise in preclinical studies, sending its shares up as much as 16 percent to their highest in more than seven months. Additional non-clinical experiments on t...
Source: http://health.yahoo.net/news/s/nm/biocryst-hep-c-drug-shows-promise-shares-jump
John Edwards Jorja Fox history Facebook
No comments:
Post a Comment
Note: only a member of this blog may post a comment.